Plasma cytokine abnormalities in drug-naïve, comorbidity-free obsessive-compulsive disorder

Psychiatry Research

Volumn 229, Issue 3, 2015, Pages 949-952

  Rao, Naren P ^a   Venkatasubramanian, Ganesan ^a   Ravi, Vasanthapuram ^a   Kalmady, Sunil ^a   Cherian, Anish ^a   Yc, Janardhan Reddy ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Cytokines; Glutamate; Inflammation; Kynurenine; OCD; Serotonin

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; IL10 PROTEIN, HUMAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; COMORBIDITY; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HAMILTON ANXIETY SCALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; MALE; MOLECULAR PATHOLOGY; NEUROPATHOLOGY; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; YALE BROWN OBSESSIVE COMPULSIVE SCALE; ANXIETY; BLOOD; CASE CONTROL STUDY; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX;

ADULT; ANXIETY; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-6; MALE; OBSESSIVE-COMPULSIVE DISORDER; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84941209176     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2015.07.009     Document Type: Article

References (49)

1. Abbas S., Khanna S., Taly A.B. Obsessive-compulsive disorder and rheumatic chorea: is there a connection?. Psychopathology 1996, 29:193-197.
2. Aoe K., Hiraki A., Murakami T., Murakami K., Makihata K., Takao K., Eda R., Maeda T., Sugi K., Darzynkiewicz Z., Takeyama H. Relative abundance and patterns of correlation among six cytokines in pleural fluid measured by cytometric bead array. Int. J. Mol. Med. 2003, 12:193-198.
3. Bebbington P.E. Epidemiology of obsessive-compulsive disorder. Br. J. Psychiatry Suppl. 1998, 35:2-6.
4. Bhattacharyya S., Chakraborty K. Glutamatergic dysfunction-newer targets for anti-obsessional drugs. Recent Pat. CNS Drug Discov. 2007, 2:47-55.
5. Bhattacharyya S., Khanna S., Chakrabarty K., Mahadevan A., Christopher R., Shankar S.K. Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive disorder. Neuropsychopharmacology 2009, 34:2489-2496.
6. Bloch M.H., Landeros-Weisenberger A., Kelmendi B., Coric V., Bracken M.B., Leckman J.F. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol. Psychiatry 2006, 11:622-632.
7. Brambilla F., Perna G., Bellodi L., Arancio C., Bertani A., Perini G., Carraro C., Gava F. Plasma interleukin-1 beta and tumor necrosis factor concentrations in obsessive-compulsive disorders. Biol. Psychiatry 1997, 42:976-981.
8. Carpenter L.L., Heninger G.R., McDougle C.J., Tyrka A.R., Epperson C.N., Price L.H. Cerebrospinal fluid interleukin-6 in obsessive-compulsive disorder and trichotillomania. Psychiatry Res. 2002, 112:257-262.
9. Cassatella M.A., Meda L., Bonora S., Ceska M., Constantin G. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J. Exp. Med. 1993, 178:2207-2211.
10. Cavaillon J.M. Pro- versus anti-inflammatory cytokines: myth or reality. Cell. Mol. Biol. 2001, 47:695-702. (Noisy-le-grand).
11. Chakrabarty K., Bhattacharyya S., Christopher R., Khanna S. Glutamatergic dysfunction in OCD. Neuropsychopharmacology 2005, 30:1735-1740.
12. da Rocha F.F., Correa H., Teixeira A.L. Obsessive-compulsive disorder and immunology: a review. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1139-1146.
13. Dale R.C., Heyman I., Giovannoni G., Church A.W. Incidence of anti-brain antibodies in children with obsessive-compulsive disorder. Br. J. Psychiatry 2005, 187:314-319.
14. Denys D., Fluitman S., Kavelaars A., Heijnen C., Westenberg H. Decreased TNF-alpha and NK activity in obsessive-compulsive disorder. Psychoneuroendocrinology 2004, 29:945-952.
15. Elshal M.F., McCoy J.P. Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods 2006, 38:317-323.
16. Fluitman S.B., Denys D.A., Heijnen C.J., Westenberg H.G. Disgust affects TNF-alpha, IL-6 and noradrenalin levels in patients with obsessive-compulsive disorder. Psychoneuroendocrinology 2010, 35:906-911.
17. Fontenelle L.F., Barbosa I.G., Luna J.V., de Sousa L.P., Abreu M.N., Teixeira A.L. A cytokine study of adult patients with obsessive-compulsive disorder. Compr. Psychiatry 2012, 53:797-804.
18. Giedd J.N., Rapoport J.L., Garvey M.A., Perlmutter S., Swedo S.E. MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection. Am. J. Psychiatry 2000, 157:281-283.
19. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L., Heninger G.R., Charney D.S. The Yale-Brown obsessive compulsive scale. I. development, use, and reliability. Arch. Gen. Psychiatry 1989, 46:1006-1011.
20. Gray S.M., Bloch M.H. Systematic review of proinflammatory cytokines in obsessive-compulsive disorder. Curr. Psychiatry Rep. 2012, 14:220-228.
21. Guy W., Bonato R. CGI: Clinical Global Impressions 1970, National Institute of Mental Health.
22. Hamilton M. The assessment of anxiety states by rating. Br. J. Med. Psychol. 1959, 32:50-55.
23. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960, 23:56-62.
24. Hodge G., Hodge S., Haslam R., McPhee A., Sepulveda H., Morgan E., Nicholson I., Zola H. Rapid simultaneous measurement of multiple cytokines using 100 microl sample volumes-association with neonatal sepsis. Clin. Exp. Immunol. 2004, 137:402-407.
25. Kenis G., Maes M. Effects of antidepressants on the production of cytokines. Int. J. Neuropsychopharmacol. 2002, 5:401-412.
26. Khanna S., John J.P., Reddy L.P. Neuroendocrine and behavioral responses to mCPP in obsessive-compulsive disorder. Psychoneuroendocrinology 2001, 26:209-223.
27. Konuk N., Tekin I.O., Ozturk U., Atik L., Atasoy N., Bektas S., Erdogan A. Plasma levels of tumor necrosis factor-alpha and interleukin-6 in obsessive compulsive disorder. Mediat. Inflamm. 2007, 2007:65704.
28. Leonard B.E., Myint A. The psychoneuroimmunology of depression. Hum. Psychopharmacol. 2009, 24:165-175.
29. Maes M., Meltzer H.Y., Bosmans E. Psychoimmune investigation in obsessive-compulsive disorder: assays of plasma transferrin, IL-2 and IL-6 receptor, and IL-1 beta and IL-6 concentrations. Neuropsychobiology 1994, 30:57-60.
30. Maes M., Song C., Lin A.H., Bonaccorso S., Kenis G., De Jongh R., Bosmans E., Scharpe S. Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacology 1999, 20:370-379.
31. Marazziti D., Presta S., Pfanner C., Gemignani A., Rossi A., Sbrana S., Rocchi V., Ambrogi F., Cassano G.B. Immunological alterations in adult obsessive-compulsive disorder. Biol. Psychiatry 1999, 46:810-814.
32. Mataix-Cols D., Rosario-Campos M.C., Leckman J.F. A multidimensional model of obsessive-compulsive disorder. Am. J. Psychiatry 2005, 162:228-238.
33. Monteleone P., Catapano F., Fabrazzo M., Tortorella A., Maj M. Decreased blood levels of tumor necrosis factor-alpha in patients with obsessive-compulsive disorder. Neuropsychobiology 1998, 37:182-185.
34. Morgan E., Varro R., Sepulveda H., Ember J.A., Apgar J., Wilson J., Lowe L., Chen R., Shivraj L., Agadir A., Campos R., Ernst D., Gaur A. Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin. Immunol. 2004, 110:252-266.
35. Murphy T.K., Benson N., Zaytoun A., Yang M., Braylan R., Ayoub E., Goodman W.K. Progress toward analysis of D8/17 binding to B cells in children with obsessive compulsive disorder and/or chronic tic disorder. J. Neuroimmunol. 2001, 120:146-151.
36. Murphy T.K., Sajid M.W., Goodman W.K. Immunology of obsessive-compulsive disorder. Psychiatr. Clin. North Am. 2006, 29:445-469.
37. Ng P.C., Li K., Wong R.P., Chui K., Wong E., Li G., Fok T.F. Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch. Dis. Child. Fetal Neonatal Ed. 2003, 88:F209-F213.
38. O'Connor M.F., Bower J.E., Cho H.J., Creswell J.D., Dimitrov S., Hamby M.E., Hoyt M.A., Martin J.L., Robles T.F., Sloan E.K., Thomas K.S., Irwin M.R. To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers. Brain Behav. Immun. 2009, 23:887-897.
39. Perlmutter S.J., Leitman S.F., Garvey M.A., Hamburger S., Feldman E., Leonard H.L., Swedo S.E. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 1999, 354:1153-1158.
40. Peterson B.S., Leckman J.F., Tucker D., Scahill L., Staib L., Zhang H., King R., Cohen D.J., Gore J.C., Lombroso P. Preliminary findings of antistreptococcal antibody titers and basal ganglia volumes in tic, obsessive-compulsive, and attention deficit/hyperactivity disorders. Arch. Gen. Psychiatry 2000, 57:364-372.
41. Rothwell N.J., Strijbos P.J. Cytokines in neurodegeneration and repair. Int. J. Dev. Neurosci. 1995, 13:179-185.
42. Schobitz B., De Kloet E.R., Holsboer F. Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain. Prog. Neurobiol. 1994, 44:397-432.
43. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59:22-33.
44. Swedo S.E. Sydenham's chorea. A model for childhood autoimmune neuropsychiatric disorders. J. Am. Med. Assoc. 1994, 272:1788-1791.
45. Swedo S.E., Leonard H.L., Garvey M., Mittleman B., Allen A.J., Perlmutter S., Lougee L., Dow S., Zamkoff J., Dubbert B.K. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am. J. Psychiatry 1998, 155:264-271.
46. van der Poll T., Jansen J., Levi M., ten Cate H., ten Cate J.W., van Deventer S.J. Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J. Exp. Med. 1994, 180:1985-1988.
47. Weizman R., Laor N., Barber Y., Hermesh H., Notti I., Djaldetti M., Bessler H. Cytokine production in obsessive-compulsive disorder. Biol. Psychiatry 1996, 40:908-912.
48. Young S.H., Antonini J.M., Roberts J.R., Erdely A.D., Zeidler-Erdely P.C. Performance evaluation of cytometric bead assays for the measurement of lung cytokines in two rodent models. J. Immunol. Methods 2008, 331:59-68.
49. Zohar J., Mueller E.A., Insel T.R., Zohar-Kadouch R.C., Murphy D.L. Serotonergic responsivity in OCD. Arch. Gen. Psychiatry 1987, 44:946-951.